Riskpilot← Back to searchSign inGet full accessHUDKLINIKK OSLO AS
ASActiveOrg 813255952Hegdehaugsveien 36B, 0352 OsloMedical specialists activities · NACE 8622Est. 20141 employees
Revenue 2024
NOK 1,2M
+6% vs 2023
EBITDA margin
0.0%
+100% vs 2023
Equity ratio
92.9%
Financial strength
Net profit 2024
NOK -292
+100% vs 2023
| Revenue | NOK 1,2M | +6% |
| EBITDA | NOK -325 | +100% |
| Net profit | NOK -292 | +100% |
| Total assets | NOK 579K | -23% |
| Equity | NOK 538K | +0% |
| Employees | 1 | — |
Legal name
HUDKLINIKK OSLO AS
Org number
813255952
Legal form
Aksjeselskap
NACE code
8622 · Medical specialists activities
Founded
18. februar 2014
Share capital
NOK 30 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Gry wigre
Company purpose
Privatpraktiserende legekontor samt investeringer i aksjer, verdipapirer, eiendom og utleie av eiendom.
Address
Hegdehaugsveien 36B, 0352 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 1 639 | 1 339 | 1 468 | 1 136 | 1 207 |
| Staff expenses | −134 | −125 | −112 | −124 | −101 |
| EBITDA | 178 | −110 | −166 | −167 | −0 |
| Depreciation & amort. | −68 | −42 | −33 | −19 | −0 |
| EBIT | 110 | −152 | −198 | −186 | −0 |
| Net financials | −0 | −0 | −1 | −0 | −0 |
| Profit before tax | 110 | −152 | −199 | −187 | −0 |
| Tax | 24 | −34 | −44 | −39 | −0 |
| Net profit | 85 | −119 | −155 | −148 | −0 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 180 | 1 102 | 910 | 753 | 579 |
| Equity | 960 | 842 | 686 | 539 | 538 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 220 | 260 | 224 | 215 | 41 |
| Total debt | 220 | 260 | 224 | 215 | 41 |
EBITDA margin
-0.0%
This company
15.8%
Market median
-100% vs market
20202024
Equity ratio
92.9%
This company
38.2%
Market median
+143% vs market
20202024
Return on equity
-0.1%
This company
18.4%
Market median
-101% vs market
20202024
Net profit margin
-0.0%
This company
8.1%
Market median
-100% vs market
20202024
Asset turnover
2.08×
This company
1.12×
Market median
+86% vs market
20202024
Debt / equity
0.08×
This company
0.62×
Market median
+87% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Board of Directors | 2014 | |
| Board of Directors | 2014 | |
| Board of Directors | 2014 | |
| Chairman | 2014 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of HUDKLINIKK OSLO AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Maya Tigalonova-Waliszewska | Board of Directors | 0 companies |
| Georg Tigalonov-Bjerke | Board of Directors | 0 companies |
| Georg Storaker Tigalonov-Bjerke | Board of Directors | 0 companies |
| Jens Roar Bjerke | Chairman | 0 companies |